PHKB and neoplasm: The second is phosphorylase b kinase regulatory subunit beta (Phkb; Kpbb), which stimulates glycogen breakdown58, and predicts poor prognosis in human hepatocellular carcinoma patients when downregulated, whereas it inhibits cell proliferation and induces apoptosis of tumor cells when artificially upregulated59.